Vol 82, No 1 (2024)
Clinical vignette
Published online: 2023-11-30

open access

Page views 493
Article views/downloads 403
Get Citation

Connect on Social Media

Connect on Social Media

18__HTML__KP_01_2024__Cader___Kurnicka___323
  • CLINICAL VIGNETTE

Serious consequences of enterococcal endocarditis in an active diving instructor

Tomasz Cader1, Agnieszka Wójcik2, Michał Ciszek3, Małgorzata Wiśniewska4, Krzysztof Wróbel5, Piotr Pruszczyk2, Katarzyna Kurnicka2

1Students` Scientific Association by Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warszawa, Poland

2Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warszawa, Poland

3Department of Transplantology, Immunology, Nephrology and Internal Medicine, Medical University of Warsaw, Warszawa, Poland

4Department of Clinical Radiology, Medical University of Warsaw, Warszawa, Poland

5Department of Cardiac Surgery, Medicover Hospital, Lazarski University, Warszawa, Poland

Correspondence to:

Katarzyna Kurnicka, Associate Professor,

Department of Internal Medicine and Cardiology,

Medical University of Warsaw,

Lindleya 4, 02–005, Warszawa, Poland

phone: +48 22 502 11 44,

fax: +48 22 502 21 42,

e-mail: kkurnicka@yahoo.pl

Copyright by the Author(s), 2024

DOI: 10.33963/v.kp.98262

Received: October 15, 2023

Accepted: November 20, 2023

Early publication date: November 30, 2023

A 58-year-old man, diving instructor, after two aortic coarctation surgeries at the age 14 and 37, with a history of mild mitral regurgitation (MR), urolithiasis, and urosepsis caused by Enterococcus faecalis 10 months earlier, was admitted with anemia, elevated C-reactive protein, D-dimer and N-terminal pro-B-type natriuretic peptide. He reported of recurring fever, sweats, back pain, and exercise intolerance over the last five months. Antibiotics, such as linezolid, vancomycin, and ampicillin with sulbactam were used for 1014 days, however, the cause of symptoms was still unexplained.

During the same period, the patient suffered an ischemic stroke in the right posterior cerebral artery and a permanent local visual loss.

Currently, blood cultures have shown Enterococcus faecalis growth again. Transthoracic echocardiography performed due to a loud systolic murmur showed severe eccentric MR (Figure 1A; Supplementary material, Video S1) and transoesophageal echocardiography (TOE) confirmed mitral valve (MV) infective endocarditis (IE) (Figure 1B). Three-dimensional TOE visualized bacterial vegetations up to 89 mm long, at the posterior mitral leaflet, a smaller one (4.5 mm) at the anterior leaflet, and a large MR jet (Figure 1C [1, 2]; Supplementary material, Video S2). No vegetations were observed at the site of aortic coarctation surgery (Figure 1D).

Figure 1. Echocardiography, magnetic resonance of the spine and PET/CT in a patient with mitral valve endocarditis. A. Eccentric jet of severe mitral regurgitation (arrow); two-dimensional transthoracic echocardiography, color Doppler (Supplementary material, Video S 1). B. Mitral valve infective endocarditis; bacterial vegetations attached to the mitral leaflets (arrows); 2-dimensional transoesophageal echocardiography; C. Bacterial vegetations attached to the posterior mitral leaflet (yellow arrows) and the anterior leaflet (white arrow) (1) and a wide jet of mitral regurgitation on color Doppler (arrow) (2); 3-dimensional transoesophageal echocardiography (Supplementary material, Video S2); D. Descending aorta at the level of the previous coarctation surgery (arrow); 2-dimensional transthoracic echocardiography (left panel), color Doppler (right panel). E. Spondylodiscitis: infectious lesions at the levels of Th10/Th11 and Th11/Th12 (arrow) and an inflammatory infiltrate in the paravertebral soft tissues (red brace); contrast-enhanced magnetic resonance. F. Post-inflammatory lesions in the spine (arrow); positron emission tomography/computed tomography

Abbreviations: AML, anterior mitral leaflet; Ao, aorta; LA, left atrium; LV, left ventricle; MR, mitral regurgitation; PML, posterior mitral leaflet

Contrast-enhanced magnetic resonance of the spine revealed spondylodiscitis infection-related lesions at the levels of Th10/Th11 and Th11/Th12 and an inflammatory infiltrate in the paravertebral soft tissues (Figure 1E). Targeted ampicillin and ceftriaxone therapy, lasting 6 weeks resulted in clinical improvement and vegetation regression on TOE. On positron emission tomography/computed tomography (PET/CT) after 4 weeks, only post-inflammatory lesions in the spine were described (Figure 1F). The patient was discharged in good condition. He underwent MV repair with implantation of a semi-rigid ring and artificial cords to the posterior leaflet.

Enterococcus faecalis is responsible for over 90% of enterococcal IE, and it has been acknowledged in the 2023 recommendations as a typical IE bacterium [1]. Some new registries indicate an increased IE incidence caused by this pathogen [2].

An early IE diagnosis is essential because E. faecalis is highly resistant and requires prolonged therapy (up to 6 weeks) of synergistic bactericidal antibiotics [1].

In the described case, the time to establish the correct diagnosis was almost 6 months, so the previous antibiotic therapy time was too short, which resulted in further complications, such as an ischemic stroke, disc inflammation, severe MR, and the need for repeated cardiac surgery.

It is worth noting, that spondylodiscitis is the most frequent hematogenous osteoarticular septic complication in the IE population, with an enterococcal etiology being one of the most common [1, 3]. In patients with spondylodiscitis and positive blood cultures with typical bacteria, echocardiography is recommended to rule out IE [1]. The role of three-dimensional TOE in diagnosing IE is indispensable, especially in precise MV assessment [4]. PET/CT is recommended in symptomatic IE patients to detect peripheral lesions [1] and is useful in monitoring their response to therapy.

A significant delay in establishing the diagnosis leads to serious consequences and contributes to higher mortality [5], therefore, we should urgently perform an echocardiogram in patients with recurrent fever and a heart murmur, back pain, or patients after previous heart surgery.

Supplementary material

Supplementary material is available at https://journals.viamedica.pl/kardiologia_polska.

Article information

Conflict of interest: None declared.

Funding: None.

Open access: This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially. For commercial use, please contact the journal office at kardiologiapolska@ptkardio.pl.

REFERENCES

  1. Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023; 44(39): 39484042, doi: 10.1093/eurheartj/ehad193, indexed in Pubmed: 37622656.
  2. Dahl A, Iversen K, Tonder N, et al. Prevalence of infective endocarditis in Enterococcus faecalis bacteremia. J Am Coll Cardiol. 2019; 74(2): 193201, doi: 10.1016/j.jacc.2019.04.059, indexed in Pubmed: 31296291.
  3. Viezens L, Dreimann M, Strahl A, et al. Spontaneous spondylodiscitis and endocarditis: interdisciplinary experience from a tertiary institutional case series and proposal of a treatment algorithm. Neurosurg Rev. 2022; 45(2): 13351342, doi: 10.1007/s10143-021-01640-z, indexed in Pubmed: 34510310.
  4. Lloyd EF, Ionescu A. Mitral cleft endocarditis presenting with confusion. Eur Heart J Cardiovasc Imaging. 2020; 21(5): 586, doi: 10.1093/ehjci/jez281, indexed in Pubmed: 31711142.
  5. Morawiec R, Matuszewska-Brycht O, Maeser P, et al. Decreasing number of valve-related infective endocarditis cases. An urgent call to action for improved diagnostic pathways: Aretrospective tertiary center perspective (20152022). Kardiol Pol. 2023, doi: 10.33963/v.kp.96587, indexed in Pubmed: 37660374.